{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:55Z","timestamp":1786985815682,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cca.2023.117274","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T15:45:02Z","timestamp":1679067902000},"page":"117274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Benzodiazepine analysis by an improved LC-MS\/MS method illustrates usage patterns in Washington State"],"prefix":"10.1016","volume":"543","author":[{"given":"Ka","family":"Keung Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey S.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Chieh","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117274_b0005","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jpainsymman.2014.03.001","article-title":"Benzodiazepines","volume":"47","author":"Howard","year":"2014","journal-title":"J. Pain. Symptom. Manage."},{"key":"10.1016\/j.cca.2023.117274_b0010","unstructured":"Diversion Control Division Drug & Chemical Evaluation Section, BENZODIAZEPINES (Street Names: Benzos, Downers, Nerve Pills, Tranks), (2019). https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/benzo.pdf (accessed November 3, 2022)."},{"key":"10.1016\/j.cca.2023.117274_b0015","article-title":"Tackling benzodiazepine misuse","volume":"362","author":"Hayhoe","year":"2018","journal-title":"BMJ."},{"key":"10.1016\/j.cca.2023.117274_b0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.310.6974.219","article-title":"Relative toxicity of benzodiazepines in overdose","volume":"310","author":"Buckley","year":"1995","journal-title":"BMJ."},{"key":"10.1016\/j.cca.2023.117274_b0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00003495-198019030-00004","article-title":"Benzodiazepines","volume":"19","author":"Bellantuono","year":"1980","journal-title":"Drugs."},{"key":"10.1016\/j.cca.2023.117274_b0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cpdd.667","article-title":"Designer Benzodiazepines: A Review of Published Data and Public Health Significance","volume":"8","author":"Greenblatt","year":"2019","journal-title":"Clin. Pharmacol. Drug. Dev."},{"key":"10.1016\/j.cca.2023.117274_b0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jat\/bky092","article-title":"A liquid-chromatography high-resolution mass spectrometry method for non-FDA approved benzodiazepines","volume":"43","author":"van Wijk","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cca.2023.117274_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: A systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug. Alcohol. Depend."},{"key":"10.1016\/j.cca.2023.117274_b0045","article-title":"Benzodiazepines reported in NFLIS-Drug, 2015 to 2018","volume":"3","author":"Bollinger","year":"2021","journal-title":"Forensic. Sci. Int."},{"key":"10.1016\/j.cca.2023.117274_b0050","unstructured":"Centers for Disease Control and Prevention, Urine Drug Testing, (2022). https:\/\/www.cdc.gov\/opioids\/providers\/prescribing\/pdf\/urine-drug-testing-508.pdf (accessed November 3, 2022)."},{"key":"10.1016\/j.cca.2023.117274_b0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jat\/bku075","article-title":"False-Positive Interferences of Common Urine Drug Screen Immunoassays: A Review","volume":"38","author":"Saitman","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cca.2023.117274_b0060","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.4155\/bio.13.244","article-title":"The challenges of LC\u2013MS\/MS analysis of opiates and opioids in urine","volume":"5","author":"French","year":"2013","journal-title":"Bioanalysis."},{"key":"10.1016\/j.cca.2023.117274_b0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/jalm.2017.023341","article-title":"Executive Summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline\u2014Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients","volume":"2","author":"Jannetto","year":"2018","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.cca.2023.117274_b0070","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.cca.2012.03.017","article-title":"Therapeutic monitoring of benzodiazepines in the management of pain: Current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety","volume":"413","author":"Mikel","year":"2012","journal-title":"Clinica. Chimica. Acta."},{"key":"10.1016\/j.cca.2023.117274_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods","volume":"93","author":"Laing","year":"2021","journal-title":"Int. J. Drug. Policy."},{"key":"10.1016\/j.cca.2023.117274_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.601827","article-title":"High-Dose Dependence and Cognitive Side Effects to Medical Prescription of Etizolam","volume":"11","author":"Tamburin","year":"2020","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.cca.2023.117274_b0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/dta.3119","article-title":"What\u2019s in fake \u2018Xanax\u2019?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets","volume":"14","author":"Blakey","year":"2022","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.cca.2023.117274_b0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jmsacl.2021.12.008","article-title":"Development of a high-throughput differential mobility separation\u2013tandem mass spectrometry (DMS-MS\/MS) method for clinical urine drug testing","volume":"23","author":"Hooshfar","year":"2022","journal-title":"J. Mass. Spectrometry. Adv. Clin. Lab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:07:24Z","timestamp":1757862444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":18,"alternative-id":["S0009898123000761"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117274","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine analysis by an improved LC-MS\/MS method illustrates usage patterns in Washington State","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117274"}}